))
Reframing Thyroid Cancer: Precision, Progress & Personalized Care
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 30, 2025 20:16 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 505871825 series 3393216
Why do thyroid cancers demand a more nuanced approach, despite high survival rates?
In this episode of Doc to Doc, Dr. Meghan Crawley, head and neck surgical oncologist at Miami Cancer Institute, joins Dr. Rachel Slotcavage, endocrine surgeon at Lynn Cancer Institute, to explore what makes thyroid cancers so unique and how treatment approaches are evolving.
From surgery and RAI therapy to targeted therapies, immunotherapy, and biomarker-driven decisions, this conversation takes a closer look at how precision medicine is shaping the future of thyroid cancer care—and what every clinician should consider in today’s multidisciplinary landscape.
Meghan Crawley, M.D.
Head and Neck Surgical Oncologist with Baptist Health Miami Cancer Institute
Rachel Slotcavage, M.D.
Endocrine surgeon with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital
33 episodes
Share
